MIRA Pharmaceuticals, Inc. (MIRA)

MIRA Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.53	4.6	0.35	2.81
Cash & Cash Equivalents	3.53	4.6	0.35	2.81
Cash Growth	261478.58%	1211.35%	-87.51%	-
Receivables	0.09	0.08	0	0
Other Current Assets	0.09	0.17	0.14	0.1
Total Current Assets	3.71	4.86	0.49	2.91
Property, Plant & Equipment	0	0.01	0.36	0
Other Long-Term Assets	0.09	0.07	0	0.45
Total Long-Term Assets	0.09	0.07	0.36	0.45
Total Assets	3.81	4.93	0.86	3.36
Accounts Payable	0.64	0.54	0.93	1.22
Current Debt	0	0.01	0.41	0.29
Other Current Liabilities	0.01	0.01	0.03	-0.42
Total Current Liabilities	0.65	0.56	1.37	1.09
Long-Term Debt	0	0	0.08	0
Total Long-Term Liabilities	0	0	0.08	0
Total Liabilities	0.65	0.56	1.45	1.09
Total Debt	0	0.01	0.49	0.29
Debt Growth	-99.65%	-98.97%	67.62%	-
Retained Earnings	-23	-21.29	-9.3	-2.24
Shareholders' Equity	3.16	4.37	-0.6	2.26
Net Cash / Debt	3.53	4.6	-0.14	2.52
Net Cash Per Share	0.18	0.25	-0.01	-
Working Capital	3.06	4.3	-0.88	1.82
Book Value Per Share	0.16	0.24	-0.03	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).